The Market Herald’s The Power Play releases new interviews with Datametrex, Group Ten Metals, Algernon Pharmaceuticals and Alianza Minerals on their latest news
VANCOUVER, BC / ACCESSWIRE / November 1, 2021 / The Market Herald’s Power Play has announced the release of new interviews with Datametrex, Group Ten Metals, Algernon Pharmaceuticals and Alianza Minerals via their latest press releases.
The Market Herald’s The Power Play offers investors a quick look at what they need to know about the company’s latest press release through exclusive insights and interviews with corporate executives.
Datametrex (TSXV: DM) (OTCQB: DTMXF) subsidiary launches personal patient care
Datametrex subsidiary Medi-Call MD has introduced personal patient care in Vancouver. Medi-Call is an advanced telemedicine company that offers technology-based e-health and m-health care services. Marshall Gunter, CEO of Datametrex, spoke to Caroline Egan to discuss the news.
For the full interview with Marshall Gunter and to learn more about the Datametrex announcement, click here.
Group Ten Metals (TSXV: PGE) (OTCQB: PGEZF) Announces First MRE for PGE-Ni-Cu-Co + Au Project Stillwater West
Group Ten Metals has released the results of the first National Instrument 43-101 independent mineral resource estimate for its Stillwater West project in Montana. Highlights include inferred mineral resources totaling 2.4 million ounces of palladium, platinum, rhodium and gold. Michael Rowley, President and CEO of Group Ten, sat with Caroline Egan to discuss the results of the estimate.
For the full interview with Michael Rowley and to learn more about the Group Ten Metal announcement, click here.
Algernon Pharmaceuticals (CSE: AGN) (OTCQB: AGNPF) determines optimal treatment period for DMT in neuron study
Algernon Pharmaceuticals has determined the optimal peak stimulation period for neuron growth through AP-188 (DMT) in its preclinical in vitro study. This current data set comes from the second part of Algernon’s in vitro experiment, which focuses on the duration of the infusion required to achieve maximum cortical neuron growth. Chris Moreau, CEO of Algernon Pharmaceuticals, spoke to Caroline Egan to discuss the news.
For the full interview with Chris Moreau and to learn more about the Algernon Pharmaceuticals announcement, click here.
Alianza Minerals (TSXV: ANZ) (OTC: TARSF) intersects high grade silver mineralization on the Haldane Silver Project
Alianza Minerals has reported additional results from the 2021 drilling campaign on the Haldane high grade silver property. The drilling has focused on the West Fault Complex target, which defines a strong vein fracture system of high grade silver mineralization. Jason Weber, P.Geo, President and CEO of Alianza, sat with Caroline Egan to review the program results.
For the full interview with Jason Weber and to learn more about the latest announcement from Alianza Mineral, click here.
Interviews for The Power Play by The Market Herald are published daily. To learn more about the companies featured in The Power Play or to explore our other interviews, visit The Market Herald’s power game.
About the market herald
The Market Herald Canada is the premier source of authoritative stock market news for self-directed investors. Our team of Canadian market reporters, editors and technologists covers the entire publicly traded corporate universe in Canada. We cover over 3,985 companies, their employees, their investors and their customers. We write the stories that move Canadian capital markets.
The market herald
SOURCE: The market herald
View source version on accesswire.com: